Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Haruka, Ikoma"'
Autor:
Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, Shinichiro Hiraiwa, Sakura Tomita, Haruka Ikoma, Yusuke Kondo, Atsushi Ito, Shunsuke Nagase, Hisanobu Miura, Giovanna Roncador, Lluis Colomo, Rifat Hamoudi, Elias Campo, Naoya Nakamura
Publikováno v:
Hematology Reports, Vol 15, Iss 1, Pp 188-200 (2023)
Diffuse large B-cell lymphoma with spindle cell morphology is a rare variant. We present the case of a 74-year-old male who initially presented with a right supraclavicular (lymph) node enlargement. Histological analysis showed a proliferation of spi
Externí odkaz:
https://doaj.org/article/c16fb2d959564aa4bad4a32461d04162
Autor:
Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, Giovanna Roncador, Juan Fernando Garcia, Shinichiro Hiraiwa, Sakura Tomita, Haruka Ikoma, Yusuke Kondo, Atsushi Ito, Yoshihiro Komohara, Naoya Nakamura, Rifat Hamoudi
Publikováno v:
Hemato, Vol 2, Iss 2, Pp 182-206 (2021)
Tumor-associated macrophages (TAMs) of the immune microenvironment play an important role in the Diffuse Large B-cell Lymphoma (DLBCL) pathogenesis. This research aimed to characterize the expression of macrophage colony-stimulating factor 1 receptor
Externí odkaz:
https://doaj.org/article/351a49fa9e794508a4e4dc8ddc468238
Autor:
Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, Shinichiro Hiraiwa, Sakura Tomita, Haruka Ikoma, Yusuke Kondo, Atsushi Ito, Naoya Nakamura, Rifat Hamoudi
Publikováno v:
AI, Vol 2, Iss 1, Pp 106-134 (2021)
The prognosis of diffuse large B-cell lymphoma (DLBCL) is heterogeneous. Therefore, we aimed to highlight predictive biomarkers. First, artificial intelligence was applied into a discovery series of gene expression of 414 patients (GSE10846). A dimen
Externí odkaz:
https://doaj.org/article/a6461498faed4acf8626366e89aa9e72
Autor:
Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, Shinichiro Hiraiwa, Sakura Tomita, Haruka Ikoma, Yusuke Kondo, Atsushi Ito, Naoya Nakamura, Rifat Hamoudi
Publikováno v:
Machine Learning and Knowledge Extraction, Vol 2, Iss 4, Pp 647-671 (2020)
Follicular lymphoma (FL) is the second most common lymphoma in Western countries. FL is characterized by being incurable, usually having an indolent clinical course with frequent relapses, and an eventual patient’s death or transformation to Diffus
Externí odkaz:
https://doaj.org/article/d1b98cf3e920442e81d768a1364b2761
Autor:
Atsushi Ito, Masashi Miyaoka, Sakura Tomita, Haruka Ikoma, Shinichiro Hiraiwa, Joaquim Carreras, Yara Yukie Kikuti, Hiroshi Kawada, Naoya Nakamura
Publikováno v:
Pathology International. 72:550-557
Diffuse large B-cell lymphoma (DLBCL) is the most common type of B-cell lymphoma. Although the multilobated subtype of DLBCL has been observed since the 1970s, little is known about the clinical significance of this unique variant in the era of ritux
Autor:
Haruka Ikoma, Masashi Miyaoka, Shinichiro Hiraiwa, Yara Yukie Kikuti, Sawako Shiraiwa, Ryujiro Hara, Minoru Kojima, Ken Ohmachi, Kiyoshi Ando, Joaquim Carreras, Naoya Nakamura
Publikováno v:
Pathology International. 72:321-331
Most follicular lymphomas (FL) show t(14;18)/IGH-BCL2 translocation, but rearrangement (R) negative cases exist. A series of 140 FL patients with a BCL2, BCL6, and MYC gene status examined by fluorescence in situ hybridization (FISH) were classified
Autor:
Atsushi Itou, Naoya Nakamura, Joaquim Carreras, Sawako Shiraiwa, Kiyoshi Ando, Sakura Tomita, Masashi Miyaoka, Haruka Ikoma, Yara Yukie Kikuti
Publikováno v:
Pathology International. 72:35-42
Diffuse large B-cell lymphoma with MYC rearrangement is defined as double/triple-hit lymphoma (DHL/THL) or single-hit lymphoma (SHL) by the inclusion of the BCL2 and BCL6 rearrangements status. DHL/THL is called as "high-grade B-cell lymphoma with MY
Autor:
Masashi Miyaoka, Yara Yukie Kikuti, Joaquim Carreras, Atsushi Ito, Haruka Ikoma, Sakura Tomita, Hiroshi Kawada, Giovanna Roncador, Silvia Bea, Elias Campo, Naoya Nakamura
Publikováno v:
Cancers; Volume 14; Issue 23; Pages: 5849
The authors thank the technicians and scientists of the Genomics Core Facility of the IDIBAPS for their assistance in performing the NGS analysis. Diffuse large B-cell lymphoma (DLBCL) with MYC alteration is classified as high-grade B-cell lymphoma w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b7da9ed298013d628365e05bd270c4c
https://hdl.handle.net/20.500.12105/16139
https://hdl.handle.net/20.500.12105/16139
Autor:
Naokata KUTSUZAWA, Hiroto TAKIGUCHI, Haruka IKOMA, Nobue KUMAKI, Tomoo NAGAI, Mitsuharu UEDA, Yoshitaka ONO, Yukihiro HORIO, Kyoko NIIMI, Naoki HAYAMA, Yoko ITO, Tsuyoshi OGUMA, Koichiro ASANO
Publikováno v:
Tokai Journal of Experimental & Clinical Medicine; Sep2023, Vol. 48 Issue 3, p91-94, 4p
Autor:
Masashi, Miyaoka, Yara Yukie, Kikuti, Joaquim, Carreras, Atsushi, Ito, Haruka, Ikoma, Sakura, Tomita, Hiroshi, Kawada, Giovanna, Roncador, Silvia, Bea, Elias, Campo, Naoya, Nakamura
Publikováno v:
Cancers. 14(23)
Diffuse large B-cell lymphoma (DLBCL) with